Survival Analysis and Clinical Outcomes between Paclitaxel and Carboplatin Versus Carboplatin and Gemcitabine in Patients with Advanced-stage Non-small-cell Lung Cancer: A Single-center Cohort Study

BACKGROUND: Palliative chemotherapy using platinum-based doublet chemotherapy was recommended as one of the standard treatments in patients with advanced-stage non-small cell lung cancer (NSCLC) with negative EGFR mutation. This study aimed to compare clinical outcomes between patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonsong, Thitaya, Usaha, Sirikade, Nakwan, Narongwit, Ruklerd, Thidarat, Khongthong, Phungern, Chang, Arunchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924342/
https://www.ncbi.nlm.nih.gov/pubmed/36308361
http://dx.doi.org/10.31557/APJCP.2022.23.10.3371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924342/
https://www.ncbi.nlm.nih.gov/pubmed/36308361
http://dx.doi.org/10.31557/APJCP.2022.23.10.3371

Ejemplares similares